Publication du rapport annuel et de l’avis de convocation à l’Assemblée générale des actionnaires

http://novacyt.com/wp-content/uploads/2019/05/Novacyt-Publication-of-Annual-Report-and-Notice-of-AGM_FRENCH-24-05-19-002.pdf Paris, France et Camberley, Royaume-Uni – 24 mai 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce aujourd’hui la publication du rapport annuel du Groupe pour l’exercice clos le 31 décembre 2018, disponible sur le site Internet du Groupe. La version imprimée du rapport annuel sera

Visit Page

Publication of Annual Report and Notice of AGM

http://novacyt.com/wp-content/uploads/2019/05/Novacyt-Publication-of-Annual-Report-and-Notice-of-AGM_ENGLISH-24-05-19.pdf Paris, France and Camberley, UK – 24 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces that the Company’s Annual Report and Accounts (“Annual Report”) for the year ended 31 December 2018 has been published and uploaded to the Company’s website. The Annual Report will also

Visit Page

Conversion of Loan Notes

http://novacyt.com/wp-content/uploads/2019/05/Novacyt-Note-Conversion-17.05.19-ENGLISH.pdf Paris, France and Camberley, UK – 17 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme announced on 23 April 2019, it has issued a tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma

Visit Page